Degranulation

The degranulation process in a Mast cell. 1 = antigen; 2 = IgE; 3 = FcεRI; 4 = preformed mediators (histamine, proteases, chemokines, heparin); 5 = granules; 6 - Mast cell; 7 - newly formed mediators (prostaglandins, leukotrienes, thromboxanes, platelet-activating factor)

Degranulation is a cellular process that releases antimicrobial cytotoxic or other molecules from secretory vesicles called granules found inside some cells. It is used by several different cells involved in the immune system, including granulocytes (neutrophils, basophils, and eosinophils) and mast cells. It is also used by certain lymphocytes such as natural killer (NK) cells and cytotoxic T cells, whose main purpose is to destroy invading microorganisms.

Mast cells

Antigens interact with IgE molecules already bound to high affinity Fc receptors on the surface of mast cells to induce degranulation. The mast cell releases a mixture of compounds, including histamine, proteoglycans, serotonin, and serine proteases from its cytoplasmic granules.^[1]

Eosinophils

In a similar mechanism, activated eosinophils release preformed mediators such as major basic protein, and enzymes such as peroxidase, following interaction between their Fc receptors and IgE molecules that are bound to large parasites like helminths.^[2][3]

Neutrophils

Four kinds of granules exist in neutrophils that display differences in content and regulation. Secretory vesicles are the most likely to release their contents by degranulation, followed by gelatinase granules, specific granules, and azurophil granules.^{[4] [5]}

Cytotoxic T cells and NK cells

Cytotoxic T cells and NK cells release molecules like perforin and granzymes by a process of directed exocytosis to kill infected target cells.^[6]

See also

• Basophil activation

External links

• Cell Degranulation at the US National Library of Medicine Medical Subject Headings (MeSH)

References

1. Yamasaki S, Saito T (2005). "Regulation of mast cell activation through FcepsilonRI". Chem Immunol Allergy. Chemical Immunology and Allergy 87: 22–31. doi:10.1159/000087568. ISBN 3-8055-7948-9. PMID 16107760.
2. David J, Butterworth A, Vadas M (1980). "Mechanism of the interaction mediating killing of Schistosoma mansoni by human eosinophils". Am J Trop Med Hyg 29 (5): 842–8. PMID 7435788.
3. Capron M, Soussi Gounni A, Morita M, Truong M, Prin L, Kinet J, Capron A (1995). "Eosinophils: from low- to high-affinity immunoglobulin E receptors". Allergy 50 (25 Suppl): 20–23. doi:10.1111/j.1398-9995.1995.tb04270.x. PMID 7677229.
4. Faurschou M, Borregaard N (2003). "Neutrophil granules and secretory vesicles in inflammation". Microbes Infect 5 (14): 1317–1327. doi:10.1016/j.micinf.2003.09.008. PMID 14613775.
5. Lominadze G, Powell D, Luerman G, Link A, Ward R, McLeish K (2005). "Proteomic analysis of human neutrophil granules". Mol Cell Proteomics 4 (10): 1503–1521. doi:10.1074/mcp.M500143-MCP200. PMID 15985654.
6. Veugelers K, Motyka B, Frantz C, Shostak I, Sawchuk T, Bleackley R (2004). "The granzyme B-serglycin complex from cytotoxic granules requires dynamin for endocytosis". Blood 103 (10): 3845–3853. doi:10.1182/blood-2003-06-2156. PMID 14739229.